TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
SLBT

SL Science Holding Limited

Healthcare · Biotechnology

1.90$ +22.9% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios SLBT
Line item 2023 2024 2025
Valuation
– – 2,679.7
– – 2,578.0
– – 2,679.2
– – 0.0%
Margins
84.0% 57.5% 35.3%
11.0% -35.6% -174.6%
45.4% -35.4% -173.8%
-300.0% 8.1% -101.5%
Returns
11.2% -20.8% -167.2%
9.4% -20.1% -135.6%
Balance Sheet & Debt
-0.1 – -1.1
-0.9 – –
84.3% 96.5% 81.1%
0.0 – 0.1
Per Share
0.00 0.00 -0.01
0.00 0.01 0.00
0.01 0.01 0.00
0.00 0.00 0.00

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?